Get an alert when BECTON DICKINSON INFUSION THERAPY UK files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Confirmation statement due

2026-11-18 (in 6mo)

Last made up 2025-11-04

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£81M

+9.1% vs 2023

Employees

371

-19.9% vs 2023

Profit before tax

£7M

-10.2% vs 2023

Accounts

2-year trend · latest reflected 2024-09-30

Metric Trend 2023-09-302024-09-30
Turnover £71,758,000£62,713,000
Operating profit £7,236,000£5,596,000
Profit before tax £7,271,000£6,532,000
Net profit £6,209,000£6,545,000
Cash
Total assets less current liabilities £89,267,000£93,539,000
Net assets £74,378,000£81,148,000
Equity £74,378,000£81,148,000
Average employees 463371
Wages £20,144,000£15,932,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-09-302024-09-30
Operating margin 10.1%8.9%
Net margin 8.7%10.4%
Return on capital employed 8.1%6.0%
Current ratio -2.12x-4.43x
Interest cover 26.51x53.30x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 101
Reporting scope
Standalone (parent only)
Auditor
Ernst & Young LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company has net current assets of £31,471,000 (2023: £17,296,000) at the year end and is dependent on the ongoing financial support of its ultimate parent undertaking, Becton, Dickinson and Company, who has confirmed to the directors of the company that this support will continue until 30 June 2026, in order to enable the company to fulfil its financial commitments as and when liabilities fall due. Accordingly, the directors have prepared these financial statements on a going concern basis.”

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 25 resigned

Name Role Appointed Born Nationality
GREEN, Robert John, Mr. Director 2022-12-21 Jun 1973 British
THOMAS, Glenn Michael, Mr. Director 2023-07-14 May 1987 British
WAKEFIELD, Ian Kurt Director 2026-05-01 Jul 1965 South African
Show 25 resigned officers
Name Role Appointed Resigned
ARNOLD, Julie Christine Secretary 1998-04-01 2008-01-08
NEYLON, Anthony Secretary 2008-01-08 2015-07-09
REED, Bryan James Secretary 1998-04-04
ADAMS, Alex, Country General Manager Director 2008-10-01 2015-07-09
ARNOLD, Julie Christine Director 1998-04-01 2017-02-16
CLOUGH, Christopher John, Dr Director 1997-09-15 1998-04-04
CLUBB, Ian Mcmaster Director 1994-09-30
CONNELL, William Edward Director 1998-04-04
ELSEY, Keith Anthony Lambert Director 1998-04-01 2000-05-17
FAIRBOURN, Michael John Director 2015-07-09 2025-12-05
GIBSON, Kathleen Director 2001-12-11 2002-09-16
GRANT, Richard Stanley Director 1995-04-11
HANSON, Alfred John Director 1998-04-01 2007-09-30
HEALY, Bridget Director 1999-10-01 2003-11-19
HOPKIN, Edward Daniel Director 2015-02-02 2022-12-21
ISAAC, Anthony Eric Director 1994-10-17 1998-04-04
LUNDGREN, Johnny Director 2011-06-28 2015-02-02
LUNDGREN, Johnny, Country General Manager Director 2007-03-01 2008-10-01
NEAT, John Konrad Director 2015-07-09 2019-11-05
NEYLON, Anthony Director 2007-03-01 2015-07-09
PEPPER, Joseph Wheeler Director 1995-04-11 1997-05-09
SAITH, Vijay Kumar Director 1998-04-04
STOLL, Roger Gerhard, Dr Director 1998-04-04
TARALLO, Angelo Nicholas Director 1994-06-01
VENKATARAMAN, Srividhya Director 2019-11-05 2023-02-02

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Bd Uk Ltd Corporate entity Significant influence 2016-09-01 Ceased 2016-09-01
Becton Dickinson Infusion Therapy Holdings Uk Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 200 total filings

Date Type Category Description
2026-05-06 AP01 officers Appoint person director company with name date PDF
2025-12-11 TM01 officers Termination director company with name termination date PDF
2025-11-17 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-04-22 AD02 address Change sail address company with old address new address PDF
2025-04-22 AA accounts Accounts with accounts type full
2025-04-17 AD03 address Move registers to sail company with new address PDF
2024-11-15 AD02 address Change sail address company with new address PDF
2024-11-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-04-16 AA accounts Accounts with accounts type full
2023-11-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-09-16 MR05 mortgage Mortgage charge whole release with charge number PDF
2023-07-24 AP01 officers Appoint person director company with name date PDF
2023-06-26 AA accounts Accounts with accounts type full
2023-02-03 TM01 officers Termination director company with name termination date PDF
2023-01-19 TM01 officers Termination director company with name termination date PDF
2023-01-19 AP01 officers Appoint person director company with name date PDF
2022-11-22 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-15 AA accounts Accounts with accounts type full
2021-11-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-06-25 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-09-30 vs 2023-09-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page